Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Kouri, Naomi, Ross, Owen A., Dombroski, Beth, Younkin, Curtis S., Serie, Daniel J., Soto-Ortolaza, Alexandra, Baker, Matthew, Finch, Ni Cole A. +46 more·2015·Nature Communications
DOI 10.1038/ncomms8247

Cited by (219)

Items 101–200 of 219

  1. Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
    Jacy Bezerra Parmera, Marcos Castello Barbosa de Oliveira, Roberta Diehl Rodriguez, Artur Martins Coutinho · 2022 · Arquivos de Neuro-Psiquiatria
  2. Progressive Supranuclear Palsy and Corticobasal Syndrome
    Alexander Y. Pantelyat · 2022 · CONTINUUM Lifelong Learning in Neurology
  3. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes
    Katherine Fodder, Megha N. Murthy, Patrizia Rizzu, Christina E. Toomey, Rahat Hasan, Jack Humphrey, Towfique Raj, Katie Lunnon, Jonathan S. Mill, Peter Heutink et al. · 2023 · Acta Neuropathologica
  4. The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
    Katherine Fodder, Rohan de Silva, Thomas T. Warner, Conceição Bettencourt · 2023 · Acta Neuropathologica Communications
  5. Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration
    K. A. Jellinger · 2023 · Journal of Neural Transmission
  6. MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
    Hadley W. Ressler, Jack Humphrey, Ricardo A. Vialle, Bergan M. Babrowicz, Shrishtee Kandoi, Towfique Raj, Dennis W. Dickson, Nilüfer Ertekin‐Taner, John F. Crary, Kurt W. Farrell · 2024 · Acta Neuropathologica Communications
  7. Atypical parkinsonism – new advances
    María Stamelou, Kailash P. Bhatia · 2016 · Current Opinion in Neurology
  8. Novel tau filament fold in corticobasal degeneration, a four-repeat tauopathy
    Wenjuan Zhang, Airi Tarutani, Kathy L. Newell, Alexey G. Murzin, Tomoyasu Matsubara, Benjamin Falcon, Rubén Vidal, Holly J. Garringer, Yang Shi, Takeshi Ikeuchi et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Common variants contribute to intrinsic human brain functional networks
    Bingxin Zhao, Tengfei Li, Stephen M. Smith, Di Xiong, Xifeng Wang, Yue Yang, Tianyou Luo, Ziliang Zhu, Yue Shan, Nana Matoba et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease
    Alexandra I. Soto‐Beasley, Ronald L. Walton, Rebecca R. Valentino, Paul W. Hook, Catherine Labbé, Michael G. Heckman, Patrick W. Johnson, Loyal A. Goff, Ryan J. Uitti, Pamela J. McLean et al. · 2020 · Parkinsonism & Related Disorders
  11. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America
    Emilia Mabel Gatto, Ricardo Allegri, Gustavo Da Prat, Patricio Chrem Méndez, David S. Hanna, Michael O. Dorschner, Ezequiel Ignacio Surace, Cyrus P. Zabetian, Ignacio Fernandez Mata · 2017 · Neurobiology of Aging
  12. Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy
    Franziska Hopfner, Anja K. Tietz, Viktoria Ruf, Owen A. Ross, Shunsuke Koga, Dennis W. Dickson, Adriano Aguzzi, Johannes Attems, Thomas Beach, Allison Beller et al. · 2022 · Movement Disorders
  13. One decade ago, one decade ahead in progressive supranuclear palsy
    María Stamelou, Nikolaos Giagkou, Günter U. Höglinger · 2019 · Movement Disorders
  14. Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
    Rebekka Kühn, Aayushi Mahajan, Peter Canoll, Gunnar Hargus · 2021 · Frontiers in Cell and Developmental Biology
  15. Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
    Nils Briel, Viktoria Ruf, Katrin Pratsch, Sigrun Roeber, Jeannine Widmann, Janina Mielke, Mario M. Dorostkar, Otto Windl, Thomas Arzberger, Jochen Wolfgang Herms et al. · 2022 · Acta Neuropathologica
  16. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations
    Claire Frances Brittain, Andrew P. McCarthy, Michael C. Irizarry, Dana McDermott, Kevin Biglan, Günter U. Höglinger, Stefan Lorenzl, Teodoro del Ser, Adam L. Boxer, David R. Williams et al. · 2018 · Parkinsonism & Related Disorders
  17. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
    Shunsuke Koga, Michael A. Metrick, Lawrence I. Golbe, Alessia Santambrogio, Minji Kim, Alexandra I. Soto‐Beasley, Ronald L. Walton, Matthew Baker, Cristhoper H. Fernandez De Castro, Michael A. Deture et al. · 2023 · Acta Neuropathologica Communications
  18. Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
    David J. Whiteside, Duncan Street, Alexander G. Murley, Peter Simon Jones, Maura Malpetti, Boyd C. P. Ghosh, Ian T S Coyle-Gilchrist, Alexander Gerhard, Michele T. Hu, Johannes Christian Klein et al. · 2023 · Human Brain Mapping
  19. MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders
    Xue‐Ning Shen, Dan Miao, Jieqiong Li, Chen‐Chen Tan, Xi‐Peng Cao, Lan Tan, Jin‐Tai Yu · 2019 · Aging
  20. Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice
    Justyna Zarȩba-Pasławska, Kalicharan Patra, Luca Kluzer, Tamás Révész, Per Svenningsson · 2021 · Frontiers in Neurology
  21. Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation
    Qi Xu, Dan Liu, Ling‐Qiang Zhu, Ying Su, He‐Zhou Huang · 2025 · Alzheimer s & Dementia
  22. Genetic landscape of Parkinson’s disease and related diseases in Luxembourg
    Zied Landoulsi, Sinthuja Pachchek, Dheeraj Reddy Bobbili, Lukas Pavelka, Patrick May, Rejko Krüger · 2023 · Frontiers in Aging Neuroscience
  23. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders
    Mang Ching Lai, Anne-Laure Bechy, Franziska Denk, Emma Collins, Maria Gavriliouk, Judith B. Zaugg, Brent James Ryan, Richard Wade‐Martins, Tara M. Caffrey · 2017 · Molecular Neurodegeneration
  24. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
    Rebecca R. Valentino, Nikoleta Tamvaka, Michael G. Heckman, Patrick W. Johnson, Alexandra I. Soto‐Beasley, Ronald L. Walton, Shunsuke Koga, Ryan J. Uitti, Zbigniew K. Wszołek, Dennis W. Dickson et al. · 2020 · Acta Neuropathologica Communications
  25. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits
    Yan Li, Yaomin Chen, Wubo Li, Xiumei Huang, Hedieh Badie-Mahdavi, Fan Jian, Timothy Y. Huang, Yingjun Zhao, Stanley N. Cohen, Limin Li et al. · 2016 · Scientific Reports
  26. Tau Diagnostics and Clinical Studies
    Illana Gozes, Günter U. Höglinger, James P. Quinn, Nigel M. Hooper, Kina Höglund · 2017 · Journal of Molecular Neuroscience
  27. Eye-brain connections revealed by multimodal retinal and brain imaging genetics in the UK Biobank
    Bingxin Zhao, Yujue Li, Zirui Fan, Zhenyi Wu, Juan Shu, Xiaochen Yang, Yilin Yang, Xifeng Wang, Bingxuan Li, Xiyao Wang et al. · 2023 · medRxiv
  28. The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk
    Nadia V. Harerimana, Alison Goate, Kathryn R. Bowles · 2022 · Frontiers in Aging Neuroscience
  29. Dynamics of microtubules and their associated proteins
    Eduardo Elias Benarroch · 2016 · Neurology
  30. iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU Expression
    Tabea Strauß, Amir Tayaranian Marvian, Eldem Sadikoglou, Ashutosh Dhingra, Florian Wegner, Dietrich Trümbach, Wolfgang Wurst, Peter Heutink, Sigrid C. Schwarz, Günter U. Höglinger · 2021 · Frontiers in Cell and Developmental Biology
  31. MOBP rs616147 Polymorphism and Risk of Amyotrophic Lateral Sclerosis in a Greek Population: A Case-Control Study
    Ioannis Liampas, Vasileios Siokas, Athina‐Maria Aloizou et al. · 2021 · Medicina
  32. The Neurogenetics of Parkinson’s Disease and Putative Links to Other Neurodegenerative Disorders
    Christina M. Lill, Christine Klein · 2017 · Elsevier eBooks
  33. MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons
    Hong Wei Xu, Qi Qiu, Peng Hu, Kevt’her Hoxha, Elliot Jang, Mia O’Reilly, Christopher Kim, Zhuohao He, Nicholas P. Marotta, Lakshmi N. Changolkar et al. · 2024 · Acta Neuropathologica
  34. Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach
    Amanda Pasqualotto, Vinícius da Silva, Felipe Mateus Pellenz, Artur Francisco Schumacher Schuh, Ida Vanessa Döederlein Schwartz, Marina Siebert · 2024 · Metabolic Brain Disease
  35. Tauopathien
    Gábor Géza Kovács, Gesine Respondek, Thilo van Eimeren, E Holler, Johannes Levin, Ulrich Müller, Sigrid C. Schwarz, Thomas W. Rösler, Kerstin Schweyer, Günter U. Höglinger · 2018 · Der Nervenarzt
  36. Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity
    Yoon A. Kim, Marian Mellén, Çağhan Kızıl, Ismael Santa‐María · 2023 · British Journal of Pharmacology
  37. Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression
    Meige Zheng, Luyan Jiao, Xiaolu Tang, Xianhong Xiang, Xiaomei Wan, Yan Yan, Xingjian Li, Guofeng Zhang, Yonglin Li, Bin Jiang et al. · 2017 · The FASEB Journal
  38. Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
    Miyoshi, Emily, Morabito, Samuel, Swarup, Vivek · 2021 · Neurobiology of Disease
  39. Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
    Federica Palacino, Paolo Manganotti, Alberto Benussi · 2025 · International Journal of Translational Medicine
  40. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations
    Alexandre Eusébio, Lejla Koric, Olivier Félician, Eric Guedj, Mathieu Pierre Ceccaldi, Jean‐Philippe Azulay · 2016 · Revue Neurologique
  41. Prevalence and clinicopathological features of primary age‐related tauopathy (PART): A large forensic autopsy study
    Koji Yoshida, Yukiko Hata, Shojiro Ichimata, Ryo Tanaka, Naoki Nishida · 2024 · Alzheimer s & Dementia
  42. Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook
    Miriam Conte, Maria Silvia De Feo, Marko Magdi Abdou Sidrak, Ferdinando Corica, Joana Gorica, Giorgia Maria Granese, Luca Filippi, Giuseppe De Vincentis, Viviana Frantellizzi · 2023 · Diagnostics
  43. Association of Genetic Polymorphisms in Immune-Related lncRNA with Osteoarthritis Susceptibility in Chinese Han Population
    Qiang Wang, Yinliang Wu, Fanian Li, Heping Zhu, Bo Zhou, Yuqiang Qian, Chi Yu Ge, Jing Xu, Liang Chen, Miao Chu et al. · 2018 · Personalized Medicine
  44. Common genetic variation is associated with longitudinal decline and network features in behavioral variant frontotemporal degeneration
    Massimo, Lauren, Rennert, Lior, Xie, Sharon X., Olm, Christopher, Bove, Jessica, Van Deerlin, Vivianna, Irwin, David J., Grossman, Murray, McMillan, Corey T. · 2021 · Neurobiology of Aging
  45. Beyond volume: Unraveling the genetics of human brain geometry
    Sabrina A. Primus, Felix Hoffstaedter, Federico Raimondo, Simon Bodo Eickhoff, Juliane Winkelmann, Konrad Oexle, Kaustubh R. Patil · 2025 · Science Advances
  46. HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance
    Maria Mirabelli, EUSEBIO D. CHIEFARI, Biagio Arcidiacono, Alessandro Salatino, Angelo Pascarella, Maurizio Morelli, Sara Carmela Credendino, Francesco S. Brunetti, Anna Di Vito, Adelaide Greco et al. · 2025 · EBioMedicine
  47. The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
    Mónica Díez-Fairén, Pilar Álvarez Jerez, Joos Berghausen · 2021 · International Journal of Molecular Sciences
  48. A Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes
    Katarzyna Gawęda-Walerych, Emilia Jadwiga Sitek, Małgorzata Borczyk, Ewa Narożańska, Bogna Brockhuis, Michał Korostyński, Michał J. Schinwelski, Mariusz Siemiński, Jarosław W. Sławek, Cezary Żekanowski · 2022 · Genes
  49. Rare Tauopathies
    Farwa Ali, Keith A. Josephs · 2019 · Seminars in Neurology
  50. Role of Amyloidogenic and Non‐Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents
    Kapali Suri, Madhu Ramesh, Mansi Bhandari, Vishakha Gupta, Virendra Kumar, Thimmaiah Govindaraju, N. Arul Murugan · 2024 · ChemBioChem
  51. Diagnostic utility of biomarkers in progressive supranuclear palsy: toward a biotyping framework
    Christine B. Ryan, Christian J. Camargo, Teddy Salan, Suresh Pallikkuth, Hanzhi Gao, Varan Govind · 2025 · Journal of Neurology
  52. Multiomics for understanding neurodegenerative disorders
    Aadil Ayaz, Aarif Ali, Irtefa Mohammed, Aanisa Nazir, Alauddin, N. Singh, Gh Jeelani, Haamid Mujtaba, Kaisar Ahmad Bhat · 2024 · Elsevier eBooks
  53. Atypical Parkinsonian Disorders
    Nahid Olfati, Fahimeh Haji Akhoundi, Irene Litvan · 2025 · Neurologic Clinics
  54. Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature
    James Fraser Rini, Breton Michael Asken, Ethan G. Geier, Katherine P. Rankin, Joel H. Kramer, Adam L. Boxer, Bruce L. Miller, Jennifer S. Yokoyama, Salvatore Spina · 2021 · Neurocase
  55. Loss of Smek1 Induces Tauopathy and Triggers Neurodegeneration by Regulating Microtubule Stability
    Ruonan Duan, Liu Ai, Yue‐Qing Sun, Yunfang Xie, Shijun Wei, Shang Gao, Yiming Liu, Xi Li, Wen‐Jie Sun, Jiangxia Li et al. · 2024 · Advanced Science
  56. Differences in the soluble and insoluble proteome between primary tauopathies
    Tomas Kavanagh, Kaleah Balcomb, Stephanie Trgovcevic, Laura R. Nementzik, Evgeny Kanshin, Glenda Margaret Halliday, Beatrix M. Ueberheide, Eleanor Drummond · 2025 · Alzheimer s & Dementia
  57. Heart-brain connections: phenotypic and genetic insights from 40,000 cardiac and brain magnetic resonance images
    Bingxin Zhao, Tengfei Li, Zirui Fan, Yue Yang, Xifeng Wang, Tianyou Luo, Jiarui Tang, Di Xiong, Zhenyi Wu, Jie Chen et al. · 2021 · medRxiv
  58. Genetic variation associated with human longevity and Alzheimer's disease risk act through microglia and oligodendrocyte cross-talk
    Graham, Andrew C, Bellou, Eftychia, Harwood, Janet C., Yaman, Umran, Celikag, Meral, Magusali, Naciye, Rambarack, Naiomi, Botia, Juan A., Frigerio, Carlo Sala, Hardy, John et al. · 2023
  59. Genome and transcriptome-wide association studies identify multiple novel loci for dementia with grain in Japanese
    Risa Mitsumori, Kouichi Ozaki, Yuko Saito, Daichi Shigemizu, Atsushi Iwata, Shigeo Murayama, Masahiro Akishita, Tomio Arai, Shumpei Niida, Kenji Toba · 2025 · Journal of Human Genetics
  60. Gene-Environment Interactions in Progressive Supranuclear Palsy
    Irene Litvan, James A. Proudfoot, Eden R. Martin, David G. Standaert, David E. Riley, Deborah A. Hall, Connie Marras, Ece Bayram, Richard Dubinsky, Yvette M. Bordelon et al. · 2021 · Frontiers in Neurology
  61. An approach to gene-based testing accounting for dependence of tests among nearby genes
    Ronald Yurko, Kathryn Roeder, Bernie Devlin, Max G’Sell · 2021 · Briefings in Bioinformatics
  62. Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  63. From a single nucleotide polymorphism to tau pathology: Appoptosin is the missing link
    Gesine Respondek, Günter U. Höglinger, María Stamelou · 2015 · Movement Disorders
  64. Progressive Supranuclear Palsy and Related Parkinsonian Disorders
    Jesse A. Brown, William W. Seeley · 2016 · Elsevier eBooks
  65. Neudefinition atypischer Parkinson-Syndrome
    Gesine Respondek, Johannes Levin, Günter U. Höglinger · 2017 · Aktuelle Neurologie
  66. Neurodegeneration and the Ordered Assembly of Tau
    Michel Goedert · 2018 · Elsevier eBooks
  67. Integrated Systems Approach Reveals Sphingolipid Metabolism Pathway Dysregulation in Association with Late-Onset Alzheimer’s Disease
    John Stephen Malamon, Andres Kriete · 2018 · Biology
  68. MAPT expression is mediated by long-range interactions with cis -regulatory elements
    Brianne B. Rogers, Ashlyn G. Anderson, Shelby N. Lauzon, M. Natalie Davis, Rebecca M. Hauser, Sydney C. Roberts, Iván Rodríguez-Nunez, Katie Trausch‐Lowther, Erin A. Barinaga, Jared W. Taylor et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  69. A microglia clonal inflammatory disorder in Alzheimer’s Disease
    Rocío Vicario, Stamatina Fragkogianni, Leslie Weber, Tomi Lazarov, Yang Hu, Samantha Y. Hayashi, Barbara P. Craddock, Nicholas D. Socci, Araitz Alberdi, Ann Baako et al. · 2024 · eLife
  70. Creating the Pick’s disease International Consortium: Association study of MAPT H2 haplotype with risk of Pick’s disease
    Rebecca R. Valentino, William J. Scotton, Shanu Faerch Roemer, Tammaryn Lashley, Michael G. Heckman, Maryam Shoai, Alejandro Martínez-Carrasco, Nicole Tamvaka, Ronald L. Walton, Matthew Baker et al. · 2023 · medRxiv
  71. Protein Pathologies in Oligodendroglia in Neurodegenerative Diseases
    Shelley L. Forrest, Gábor Géza Kovács · 2025 · Advances in neurobiology
  72. Genetic-based diagnostics of Parkinson’s disease and other Parkinsonian syndromes
    Emma N. Somerville, Ziv Gan‐Or · 2024 · Expert Review of Molecular Diagnostics
  73. Corticobasal Degeneration and Corticobasal Syndrome
    Gerard Saranza, Melissa J. Armstrong, Anthony Edward Lang · 2025 · Cambridge University Press eBooks
  74. Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants
    Cristina Razquín, Sara Ortega‐Cubero, Estefanía Rojo-Bustamante et al. · 2018 · Neurobiology of Aging
  75. Novel Therapeutic Targets and Biomarkers for the Treatment of Progressive Supranuclear Palsy
    Imogen Tyer, Alison Hill · 2020 · Preprints.org
  76. A microglia clonal inflammatory disorder in Alzheimer’s Disease
    Rocío Vicario, Stamatina Fragkogianni, Leslie Weber, Tomi Lazarov, Yang Hu, Samantha Y. Hayashi, Barbara P. Craddock, Nicholas D. Socci, Araitz Alberdi, Ann Baako et al. · 2024 · eLife
  77. Redefinition of Atypical Parkinsonian Syndromes
    Gesine Respondek, Johannes Levin, Günter U. Höglinger · 2017 · Neurology International Open
  78. Flortaucipir imaging of MAPT
    Corey T. McMillan, Edward D. Huey · 2018 · Neurology
  79. Corticobasal degeneration/progressive supranuclear palsy
    下畑 享良 · 2018 · 神経治療学
  80. Partitioning the genetic architecture of amyotrophic lateral sclerosis
    Iris Broce, Chun Chieh Fan, Nicholas T. Olney, Catherine Lomen‐Hoerth, Steven M. Finkbeiner, Nazem Atassi, Merit Cudkowicz, Sabrina Paganoni, Jennifer S. Yokoyama, Aimee W. Kao et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  81. WITHDRAWN: Genetics of Parkinson’s disease
    Christina M. Lill · 2020 · Molecular and Cellular Probes · Retracted
  82. Evaluation Of The Rims2 Locus As A Risk Locus For Parkinson’s Disease Dementia
    Manuela M. X. Tan, Raquel Real, A Lawton Michael et al. · 2021 · medRxiv
  83. Genetics of Dementia
    Alan Edward Renton, Alison Goate · 2017 · Oxford University Press eBooks
  84. Parkinsonism and other extrapyramidal diseases
    Elisaveta Sokolov, Vinod Metta, К. Ray Chaudhuri · 2020
  85. Behavioral Abnormalities and Cognitive Impairment in Rare Dementia Syndromes, Progressive Supranuclear Palsy, Huntington Disease and Sporadic Creutzfeldt-Jakob Disease
    Ophir Keret · 2020 · Elsevier eBooks
  86. The MAPT p.P301L mutation presents as a rare early-onset corticobasal syndrome: A case report
    Cheng‐Hsuan Li, Ni‐Chung Lee, Kun‐Ju Lin, Ing‐Tsung Hsiao, Yi-Hsin Weng, Chin‐Hsien Lin · 2023 · Neurology Asia
  87. Criteri diagnostici delle degenerazioni corticobasali
    Isabelle Bénatru, Olivier Colin · 2019 · EMC - Neurologia
  88. Association of Pick's disease with the MAPT H2 haplotype
    Gaël Nicolas · 2024 · The Lancet Neurology
  89. Long-read transcriptomics in neurodegeneration
    Emil Karl Gustavsson, Hannah L. Macpherson · 2024 · Elsevier eBooks
  90. 10.1016/s0246-0378(18)61004-8
    2000 · Time to knit
  91. Molecular and Cellular Mechanisms of Primary Tauopathies
    Shiaoching Gong, Li Gan · 2025 · Oxford University Press eBooks
  92. 17q21.31 locus regulates Parkinson’s disease relevant pathways through KANSL1 activity
    Amy R. Hicks, Benjamin O’Callaghan, Jonathan Brenton, Melissa Grant‐Peters, Aine Fairbrother-Browne, Guillermo Rocamora Perez, Caitlin A. Loh, Regina Hertfelder Reynolds, Emil Karl Gustavsson, Kylie Montgomery et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Criteri diagnostici delle degenerazioni corticobasali
    Isabelle Bénatru, Olivier Colin · 2025 · EMC - Neurologia
  94. Genomic and Functional studies identify RPSA as a risk gene for ALS and other neurological diseases
    Xiaoyu Qian, Brett William Stringer, Cheong W. Wong et al. · 2025 · medRxiv
  95. The Cognitive Neurology of Corticobasal Degeneration and Progressive Supranuclear Palsy
    Suzee E. Lee, Carolyn A. Fredericks · 2025 · Cambridge University Press eBooks
  96. Additional file 12 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Yiyuan Liu, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
  97. Additional file 1 of MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
    Hadley W. Ressler, Jack Humphrey, Ricardo A. Vialle, Bergan M. Babrowicz, Shrishtee Kandoi, Towfique Raj, Dennis W. Dickson, Ertekin-Taner, Nilüfer, John Crary, Kurt W. Farrell · 2024 · Figshare
  98. Additional file 3 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
  99. Additional file 15 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
  100. Additional file 8 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare